Drug intelligence / Profile preview

16055 DG4 NFL clade C trimer

Development stage
Preclinical
Lead developer
International AIDS Vaccine Initiative
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

**16055 DG4 NFL clade C trimer** is a stabilized, cleavage-independent, native flexibly linked (NFL) HIV-1 envelope (Env) glycoprotein trimer derived from the clade C isolate 16055. It features structure-guided modifications including TD (trimer-derived) stabilizing mutations, CC (cysteine-cysteine) linkages for conformational stability, and a flexible glycine-serine linker replacing the furin cleavage site to enable proper folding, glycan processing, and quaternary assembly without co-transfection of furin protease. Produced at high yields (up to cGMP-compatible levels) in CHO cell lines, it displays a native-like closed structure, preferential recognition by broadly neutralizing antibodies (bNAbs) such as PGT145, PG16, PGDM1400, and VRC01, minimal binding by non-neutralizing antibodies (e.g., F105, V3-directed), and an oligomannose-dominated N-glycan shield (68% oligomannose-type). Developed as an HIV vaccine immunogen, it elicits robust tier 2 autologous neutralizing antibody responses against the 16055 virus in rabbits, non-human primates, and guinea pigs, with superior germinal center formation and neutralization when arrayed on liposomes or formulated in adjuvants like Matrix-M or SAS, while maintaining low V3-directed responses.

Other names
16055 NFL trimer
02

Targets

Env (HIV-1 envelope glycoprotein)

Beyond the preview

Go deeper on 16055 DG4 NFL clade C trimer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 16055 DG4 NFL clade C trimer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call